{
    "N/R/U": null,
    "Applicant": "Sumitomo Pharma Switzerland GmbH ",
    "BLA Number": "125685",
    "Proprietary Name": "Rethymic",
    "Proper Name": "allogeneic processed thymus tissue-agdc",
    "BLA Type": "351(a)",
    "Strength": "SEMI-QUANTITATIVE",
    "Dosage Form": "For Suspension",
    "Route of Administration": "Implantation",
    "Product Presentation": "Dish",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "8-Oct-21",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2368",
    "Product Number": "1",
    "Center": "CBER",
    "Date of First Licensure": "8-Oct-21",
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": "8-Oct-33",
    "Orphan Exclusivity Exp. Date": "8-Oct-28"
}